Cita APA

Delgado, J., Voltz, C., Stain, M., Lapveteläinen, T., Urach, S., Lähteenvuo, J., . . . Pignatti, F. (2021). The European Medicines Agency Review of Crizanlizumab for the Prevention of Recurrent Vaso-Occlusive Crises in Patients With Sickle Cell Disease. Hemasphere.

Chicago Style Citation

Delgado, Julio, et al. "The European Medicines Agency Review of Crizanlizumab for the Prevention of Recurrent Vaso-Occlusive Crises in Patients With Sickle Cell Disease." Hemasphere 2021.

Cita MLA

Delgado, Julio, et al. "The European Medicines Agency Review of Crizanlizumab for the Prevention of Recurrent Vaso-Occlusive Crises in Patients With Sickle Cell Disease." Hemasphere 2021.